(Q39625971)

English

MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research

scientific article published on 30 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research (English)

1 reference

Europe PubMed Central

13 September 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

Weifeng Ke

1

1 reference

Europe PubMed Central

13 September 2017

Pei Yu

2

1 reference

Europe PubMed Central

13 September 2017

Jianfeng Wang

3

1 reference

Europe PubMed Central

13 September 2017

Ruitao Wang

4

1 reference

Europe PubMed Central

13 September 2017

Chongyong Guo

5

1 reference

Europe PubMed Central

13 September 2017

Ling Zhou

6

1 reference

Europe PubMed Central

13 September 2017

Changchun Li

7

1 reference

Europe PubMed Central

13 September 2017

Ke Li

8

1 reference

Europe PubMed Central

13 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 November 2010

1 reference

Europe PubMed Central

13 September 2017

Medical Oncology

1 reference

Europe PubMed Central

13 September 2017

28 Suppl 1

1 reference

Europe PubMed Central

13 September 2017

S135-41

1 reference

Europe PubMed Central

13 September 2017

describes a project that uses

0 references

https://scigraph.springernature.com/pub.10.1007/s12032-010-9747-1

0 references

A gene expression database for the molecular pharmacology of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Multidrug-resistant MCF-7 cells: an identity crisis?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Proteomic phenotyping: metastatic and invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

DNA fingerprinting of the NCI-60 cell line panel

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Short tandem repeat profiling provides an international reference standard for human cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Proteomics reveals protein profile changes in doxorubicin--treated MCF-7 human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Topoisomerase II inhibition involves characteristic chromosomal expression patterns

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Persistent use of "false" cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

Eradication of cross-contaminated cell lines: a call for action

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9747-1

21 January 2018

UKCCCR guidelines for the use of cell lines in cancer research

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotypic complexity of the NCI-60 drug-screening panel.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21116879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-010-9747-1

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39625971&oldid=1847757856"